Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
International Journal of Pharmaceutics|March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoidsC S Maia, W Mehnert, M Schäfer-Korting
Advanced Drug Delivery Reviews|June 5, 2007
Lipid nanoparticles for improved topical application of drugs for skin diseasesMonika Schäfer-Korting, Wolfgang Mehnert, Hans-Christian Korting
Acta Pharmaceutica (Zagreb, Croatia)|November 5, 2020
Ultraviolet B irradiation-induced keratinocyte senescence and impaired development of 3D epidermal reconstructSuvara K Wattanapitayakul, Linda Chularojmontri, Monika Schäfer-Korting
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratioC Schackert, H C Korting, M Schäfer-Korting
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 27, 2007
Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates. Results of National Health Surveys from 1984 to 1999Yong Du, Hans-Ulrich Melchert, Monika Schäfer-Korting
Nanotoxicology|October 7, 2014
Perspectives on percutaneous penetration: Silica nanoparticlesShohreh Nafisi, Monika Schäfer-Korting, Howard I Maibach
Mycoses|September 1, 1996
Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular riskM Schäfer-Korting, J Blechschmidt, H C Korting
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1988
[In vitro bactericidal effects of ofloxacin on S. aureus]H C Korting, W Maier, M Schäfer-Korting
Archiv Der Pharmazie|August 1, 1985
[Morphologic, biochemical and pharmacokinetic studies on suction blisters in relationship to their nature and time of formation]M Schäfer-Korting, H W Grimm, E Mutschler
Skin Pharmacology and Physiology|May 30, 2008
Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedisM Schäfer-Korting, C Schoellmann, H C Korting
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
International Journal of Pharmaceutics|March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoidsC S Maia, W Mehnert, M Schäfer-Korting
Advanced Drug Delivery Reviews|June 5, 2007
Lipid nanoparticles for improved topical application of drugs for skin diseasesMonika Schäfer-Korting, Wolfgang Mehnert, Hans-Christian Korting
Acta Pharmaceutica (Zagreb, Croatia)|November 5, 2020
Ultraviolet B irradiation-induced keratinocyte senescence and impaired development of 3D epidermal reconstructSuvara K Wattanapitayakul, Linda Chularojmontri, Monika Schäfer-Korting
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratioC Schackert, H C Korting, M Schäfer-Korting
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 27, 2007
Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates. Results of National Health Surveys from 1984 to 1999Yong Du, Hans-Ulrich Melchert, Monika Schäfer-Korting
Nanotoxicology|October 7, 2014
Perspectives on percutaneous penetration: Silica nanoparticlesShohreh Nafisi, Monika Schäfer-Korting, Howard I Maibach
Mycoses|September 1, 1996
Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular riskM Schäfer-Korting, J Blechschmidt, H C Korting
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1988
[In vitro bactericidal effects of ofloxacin on S. aureus]H C Korting, W Maier, M Schäfer-Korting
Archiv Der Pharmazie|August 1, 1985
[Morphologic, biochemical and pharmacokinetic studies on suction blisters in relationship to their nature and time of formation]M Schäfer-Korting, H W Grimm, E Mutschler
Skin Pharmacology and Physiology|May 30, 2008
Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedisM Schäfer-Korting, C Schoellmann, H C Korting
Pageof 22